Thalidomide treatment in advanced refractory myeloma

Comment

B Myers et al. Br J Haematol. 2000 Dec.

. 2000 Dec;111(3):986.

No abstract available

Comment in

Thalidomide and low-dose dexamethasone in myeloma treatment.
Myers B, Grimley C, Dolan G. Myers B, et al. Br J Haematol. 2001 Jul;114(1):245. doi: 10.1046/j.1365-2141.2001.02873-5.x. Br J Haematol. 2001. PMID: 11472379 No abstract available.
Analysis of durability of response to thalidomide treatment for relapsed myeloma patients.
Myers B, Dolan G. Myers B, et al. Br J Haematol. 2002 Jul;118(1):347. doi: 10.1046/j.1365-2141.2002.03576_4.x. Br J Haematol. 2002. PMID: 12100175 No abstract available.

Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma.
Juliusson G, Celsing F, Turesson I, Lenhoff S, Adriansson M, Malm C. Juliusson G, et al. Br J Haematol. 2000 Apr;109(1):89-96. doi: 10.1046/j.1365-2141.2000.01983.x. Br J Haematol. 2000. PMID: 10848786